Syngene International Reports Rs 32.2 Crore Q2 Profit, Sequential Revenue Growth
Syngene International reported a net profit of Rs 32.2 crore in Q2 FY27, recovering from a Rs 9 crore loss in the previous quarter but down 108% year-on-year from Rs 67.1 crore. Revenue declined 9% year-on-year to Rs 832.7 crore but rose 13% sequentially. Operating EBITDA margin improved by 6 percentage points to 18%. The company highlighted growth in its CDMO business and signed its first manufacturing agreement for the Bayview biologics facility in the US, aiming to strengthen global capabilities and sustainable growth.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (59/100). Lens Score 36/100.
Outlets measured: freepressjournal, english, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 27 Oct, 07:02 pm. Other outlets followed.